Portfolio Manager Factsheet
Volatility subsided in the month driven primarily by increased investor optimism over a potential interest rate cut by the U.S. Federal Reserve and easing tensions over U.S.-China trade negotiations. Boston Scientific’s share price was driven by a better-than-expected outcome from a U.S. Food and Drug Administration Advisory Committee meeting for one of the company’s key device categories and a robust investor day which highlighted the company’s pipeline and increased investor confidence.
Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.